These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 26498270)

  • 1. To dry or not too dry: should we be more tolerant of stable subretinal fluid in patients receiving anti-vascular endothelial growth factor treatment for neovascular age-related macular degeneration?
    Razavi H; Arnold J; Guymer R
    Clin Exp Ophthalmol; 2015 Nov; 43(8):707-10. PubMed ID: 26498270
    [No Abstract]   [Full Text] [Related]  

  • 2. REFRACTORY INTRARETINAL OR SUBRETINAL FLUID IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION TREATED WITH INTRAVITREAL RANIZUBIMAB: Functional and Structural Outcome.
    Gianniou C; Dirani A; Jang L; Mantel I
    Retina; 2015 Jun; 35(6):1195-201. PubMed ID: 25650710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neovascular AMD with marked macular fluid and rapid response to anti-VEGF therapy.
    Wood E; Chang JS; Flynn HW; Kitchens JW
    Ophthalmic Surg Lasers Imaging Retina; 2014; 45(2):175-8. PubMed ID: 24512809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Visual and anatomical outcomes of intravitreal aflibercept in eyes with persistent subfoveal fluid despite previous treatments with ranibizumab in patients with neovascular age-related macular degeneration.
    Kumar N; Marsiglia M; Mrejen S; Fung AT; Slakter J; Sorenson J; Freund KB
    Retina; 2013 Sep; 33(8):1605-12. PubMed ID: 23549101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrovascular pigment epithelial detachment is a risk factor for long-term visual decay in neovascular age-related macular degeneretion.
    Hoerster R; Muether PS; Sitnilska V; Kirchhof B; Fauser S
    Retina; 2014 Sep; 34(9):1767-73. PubMed ID: 24936942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of 3-Dimensionally Quantified Intraretinal and Subretinal Fluid With Visual Acuity in Neovascular Age-Related Macular Degeneration.
    Waldstein SM; Philip AM; Leitner R; Simader C; Langs G; Gerendas BS; Schmidt-Erfurth U
    JAMA Ophthalmol; 2016 Feb; 134(2):182-90. PubMed ID: 26661463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aflibercept therapy for exudative age-related macular degeneration resistant to bevacizumab and ranibizumab.
    Bakall B; Folk JC; Boldt HC; Sohn EH; Stone EM; Russell SR; Mahajan VB
    Am J Ophthalmol; 2013 Jul; 156(1):15-22.e1. PubMed ID: 23706500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Visual outcomes in relation to time to treatment in neovascular age-related macular degeneration.
    Real JP; Luna JD
    Acta Ophthalmol; 2016 Dec; 94(8):e803. PubMed ID: 27417383
    [No Abstract]   [Full Text] [Related]  

  • 9. Relationship Between Subretinal Hyperreflective Material Reflectivity and Volume in Patients With Neovascular Age-Related Macular Degeneration Following Anti-Vascular Endothelial Growth Factor Treatment.
    Charafeddin W; Nittala MG; Oregon A; Sadda SR
    Ophthalmic Surg Lasers Imaging Retina; 2015 May; 46(5):523-30. PubMed ID: 26057755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morphologic parameters relevant for visual outcome during anti-angiogenic therapy of neovascular age-related macular degeneration.
    Simader C; Ritter M; Bolz M; Deák GG; Mayr-Sponer U; Golbaz I; Kundi M; Schmidt-Erfurth UM
    Ophthalmology; 2014 Jun; 121(6):1237-45. PubMed ID: 24684838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pigment epithelial detachment followed by retinal cystoid degeneration leads to vision loss in treatment of neovascular age-related macular degeneration.
    Schmidt-Erfurth U; Waldstein SM; Deak GG; Kundi M; Simader C
    Ophthalmology; 2015 Apr; 122(4):822-32. PubMed ID: 25578255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Geographic atrophy in patients receiving anti-vascular endothelial growth factor for neovascular age-related macular degeneration.
    Xu L; Mrejen S; Jung JJ; Gallego-Pinazo R; Thompson D; Marsiglia M; Freund KB
    Retina; 2015 Feb; 35(2):176-86. PubMed ID: 25387047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors Influencing the Treatment Response of Pigment Epithelium Detachment in Age-Related Macular Degeneration.
    Dirani A; Ambresin A; Marchionno L; Decugis D; Mantel I
    Am J Ophthalmol; 2015 Oct; 160(4):732-8.e2. PubMed ID: 26144701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognosti implications of pigment epithelial detachment in bevacizumab (avastin)-treated eyes with age-related macular degeneration and choroidal neovascularization.
    Freeman WR; Kozak I; Yuson RM; Nigam N; Cheng L; Mojana F
    Retina; 2011 Oct; 31(9):1812-8. PubMed ID: 21866073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of Fluid in Neovascular Age-related Macular Degeneration: To Mop it, to Dab it, or to Leave it?
    Sharma A; Kumar N; Singh S; Regillo CD; Freund KB
    Retina; 2020 Aug; 40(8):1451-1455. PubMed ID: 32568979
    [No Abstract]   [Full Text] [Related]  

  • 16. Association between choroidal thickness and the response to intravitreal ranibizumab injection in age-related macular degeneration.
    Shin JY; Kwon KY; Byeon SH
    Acta Ophthalmol; 2015 Sep; 93(6):524-32. PubMed ID: 25581639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retreatment with anti-vascular endothelial growth factor therapy based on changes in visual acuity after initial stabilization of neovascular age-related macular degeneration: 3-year follow-up results.
    Dunavoelgyi R; Sacu S; Eibenberger K; Palkovits S; Leydolt C; Pruente C; Schmidt-Erfurth U
    Retina; 2012 Sep; 32(8):1471-9. PubMed ID: 22414958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Notion of tolerating subretinal fluid in neovascular AMD: understanding the fine print before the injection pause.
    Sharma A; Parachuri N; Kumar N; Bandello F; Kuppermann BD; Loewenstein A; Regillo CD; Chakravarthy U
    Br J Ophthalmol; 2021 Feb; 105(2):149-150. PubMed ID: 32980815
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of wet age-related macular degeneration by ranibizumab in "real life" in France: treatment behaviours and associated visual outcome.
    Souied EH; Cohen SY; de Pouvourville G; Dupeyron G; Latour E; Ponthieux A; Weber M
    Acta Ophthalmol; 2015 Mar; 93(2):e179-80. PubMed ID: 25377519
    [No Abstract]   [Full Text] [Related]  

  • 20. Outcomes of persistently active neovascular age-related macular degeneration treated with VEGF inhibitors: observational study data.
    Barthelmes D; Walton R; Campain AE; Simpson JM; Arnold JJ; McAllister IL; Guymer RH; Hunyor AP; Essex RW; Morlet N; Gillies MC;
    Br J Ophthalmol; 2015 Mar; 99(3):359-64. PubMed ID: 25249615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.